ROS-triggered transformation of microgels to bioadhesive patch for orally administrated treatment of inflammatory bowel disease.

Inflammatory bowel diseases (IBD) are driven by excessive reactive oxygen species (ROS) and progressive disruption of the intestinal mucus barrier, yet sustained mucosal protection remains insufficiently addressed by current therapies. Here, we devel…

Preview only. Read the full abstract at the source